Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTE: AL vs ASAQ for Uncomplicated Malaria in Burkina Faso
NCT01017770Phase 4Completed
- Sponsor
- Centre Muraz
- Start
- Sep 2008
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of artemether + lumefantrine, artesunate + amodiaquine in Plasmodium falciparum malaria, sponsored by Centre Muraz. Started Sep 2008; status: completed.
02
Drugs
artemether + lumefantrineartesunate + amodiaquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01017770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01017770.